{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:24:50Z","timestamp":1777566290463,"version":"3.51.4"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.17126","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T16:35:28Z","timestamp":1576082128000},"page":"e1917126","source":"Crossref","is-referenced-by-count":36,"title":["Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease"],"prefix":"10.1001","volume":"2","author":[{"given":"Jorge J.","family":"Llibre-Guerra","sequence":"first","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Radiology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Fagan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"},{"name":"Hope Center for Neurological Disorders, St Louis, Missouri"},{"name":"Knight Alzheimer\u2019s Disease Research Center, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammie L. S.","family":"Benzinger","sequence":"additional","affiliation":[{"name":"Department of Radiology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Hassenstab","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research, Department of Cellular Neurology, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Allegri","sequence":"additional","affiliation":[{"name":"Department of Cognitive Neurology, Institute for Neurological Research Fleni, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah B.","family":"Berman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Washington University in St Louis, St Louis, Missouri"},{"name":"Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmeer","family":"Chhatwal","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[{"name":"Neuroscience Center, Indiana University, Bloomington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"},{"name":"Hope Center for Neurological Disorders, St Louis, Missouri"},{"name":"Knight Alzheimer\u2019s Disease Research Center, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Jucker","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research, Department of Cellular Neurology, University of T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"DZNE-German Center for Neurodegenerative Diseases, T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ludwig-Maximilians-University, Munich, Germany"},{"name":"DZNE-German Center for Neurodegenerative Diseases, Munich, Munich, Germany"},{"name":"SyNergy, Munich Cluster for Systems Neurology, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Noble","sequence":"additional","affiliation":[{"name":"Taub Institute for Research on Alzheimer\u2019s Disease, Aging Brain G.H. Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Salloway","sequence":"additional","affiliation":[{"name":"Memory & Aging Program, Butler Hospital, Brown University, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schofield","sequence":"additional","affiliation":[{"name":"Neuroscience Research Australia, Randwick, Sydney, New South Wales, Australia"},{"name":"School of Medical Sciences, UNSW Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Karch","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"McDade","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"issue":"11","key":"zoi190648r1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"zoi190648r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging: Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"11","key":"zoi190648r3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jalz.2014.12.006","article-title":"CSF biomarkers for the differential diagnosis of Alzheimer\u2019s disease: a large-scale international multicenter study.","volume":"11","author":"Ewers","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"4","key":"zoi190648r4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.dadm.2015.09.001","article-title":"Revolutionizing Alzheimer\u2019s disease and clinical trials through biomarkers.","volume":"1","author":"Mattsson","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3","key":"zoi190648r5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"9","key":"zoi190648r6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease.","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi190648r7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"zoi190648r8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects.","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi190648r9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade.","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"zoi190648r10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jama.2009.1073","article-title":"Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.","volume":"302","author":"Petersen","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"zoi190648r11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"zoi190648r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach.","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"226","key":"zoi190648r13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease.","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci Transl Med"},{"issue":"14","key":"zoi190648r14","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"zoi190648r15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jalz.2018.01.012","article-title":"Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer\u2019s disease.","volume":"14","author":"Sutphen","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"7","key":"zoi190648r16","doi-asserted-by":"publisher","first-page":"P1170","DOI":"10.1016\/j.jalz.2018.06.1611","article-title":"Serum neurofilament light chain levels are associated with CSF neurofilament light chain, cognitive status, and disease progression in autosomal dominant AD.","volume":"14","author":"Preische","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"5","key":"zoi190648r17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jalz.2018.12.019","article-title":"Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer\u2019s disease.","volume":"15","author":"Schindler","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"zoi190648r18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0361-9230(03)00087-X","article-title":"Advances in the development of biomarkers for Alzheimer\u2019s disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein.","volume":"61","author":"Hampel","year":"2003","journal-title":"Brain Res Bull"},{"issue":"13","key":"zoi190648r19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer\u2019s disease: a case series.","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol"},{"issue":"10","key":"zoi190648r20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4155\/cli.12.93","article-title":"Developing an international network for Alzheimer\u2019s research: the Dominantly Inherited Alzheimer Network.","volume":"2","author":"Morris","year":"2012","journal-title":"Clin Investig (Lond)"},{"issue":"5","key":"zoi190648r21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Extreme cerebrospinal fluid amyloid \u00df levels identify family with late-onset Alzheimer\u2019s disease presenilin 1 mutation.","volume":"61","author":"Kauwe","year":"2007","journal-title":"Ann Neurol"},{"issue":"11","key":"zoi190648r22","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"zoi190648r23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.","volume":"5","author":"Moulder","year":"2013","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"zoi190648r24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"zoi190648r25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jalz.2010.03.004","article-title":"Update on the magnetic resonance imaging core of the Alzheimer\u2019s disease neuroimaging initiative.","volume":"6","author":"Jack","year":"2010","journal-title":"Alzheimers Dement"},{"issue":"2","key":"zoi190648r26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer.","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"issue":"3","key":"zoi190648r27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study.","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol"},{"issue":"11","key":"zoi190648r28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease.","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"zoi190648r29","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/brain\/awl256","article-title":"Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer\u2019s disease.","volume":"129","author":"Singh","year":"2006","journal-title":"Brain"},{"key":"zoi190648r30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2018.01.024","article-title":"Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.","volume":"66","author":"Das","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"4","key":"zoi190648r31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/brain\/awz019","article-title":"Tau PET in autosomal dominant Alzheimer\u2019s disease: relationship with cognition, dementia and other biomarkers.","volume":"142","author":"Gordon","year":"2019","journal-title":"Brain"},{"issue":"5","key":"zoi190648r32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u00df-amyloid (1-42) in human cerebrospinal fluid.","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"11","key":"zoi190648r33","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u00df PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts.","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"zoi190648r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","article-title":"NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers.","volume":"44","author":"Vos","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"6","key":"zoi190648r35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/bimj.201400131","article-title":"Bivariate correlation coefficients in family-type clustered studies.","volume":"57","author":"Luo","year":"2015","journal-title":"Biom J"},{"issue":"16","key":"zoi190648r36","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0000000000002593","article-title":"Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.","volume":"86","author":"Xiong","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"zoi190648r37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"zoi190648r38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","article-title":"Longitudinal change in CSF Tau and A\u00df biomarkers for up to 48 months in ADNI.","volume":"126","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"2","key":"zoi190648r39","first-page":"325","article-title":"Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria.","volume":"19","author":"Sperling","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"zoi190648r40","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system.","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"issue":"194","key":"zoi190648r41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006446","article-title":"Changes in amyloid-\u00df and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.","volume":"5","author":"Maia","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"zoi190648r42","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jalz.2016.09.005","article-title":"Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.","volume":"13","author":"Schelle","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"6","key":"zoi190648r43","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000290","article-title":"Amyloid- and tau-PET imaging in a familial prion kindred.","volume":"4","author":"Jones","year":"2018","journal-title":"Neurol Genet"},{"issue":"11","key":"zoi190648r44","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1212\/WNL.0000000000005117","article-title":"In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms.","volume":"90","author":"Jones","year":"2018","journal-title":"Neurology"},{"issue":"369","key":"zoi190648r45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1767","article-title":"Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury.","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7685","key":"zoi190648r46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u00df in Alzheimer\u2019s disease.","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"issue":"5","key":"zoi190648r47","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","article-title":"Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease.","volume":"75","author":"Quiroz","year":"2018","journal-title":"JAMA Neurol"},{"issue":"4","key":"zoi190648r48","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3233\/JAD-2011-101911","article-title":"Longitudinal changes of CSF biomarkers in Alzheimer\u2019s disease.","volume":"25","author":"Sepp\u00e4l\u00e4","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"zoi190648r49","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00702-004-0235-7","article-title":"Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer\u2019s disease.","volume":"112","author":"Mollenhauer","year":"2005","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"zoi190648r50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jalz.2017.06.2268","article-title":"Presymptomatic atrophy in autosomal dominant Alzheimer\u2019s disease: a serial magnetic resonance imaging study.","volume":"14","author":"Kinnunen","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"21","key":"zoi190648r51","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration.","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"zoi190648r52","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease.","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"issue":"7","key":"zoi190648r53","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease.","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"issue":"2","key":"zoi190648r54","first-page":"147","article-title":"TDP-43 in aging and Alzheimer\u2019s disease: a review.","volume":"4","author":"Wilson","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"zoi190648r55","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"issue":"2","key":"zoi190648r56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","article-title":"Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease.","volume":"126","author":"Nelson","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"5","key":"zoi190648r57","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/brain\/aws076","article-title":"Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia.","volume":"135","author":"Gefen","year":"2012","journal-title":"Brain"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2757369\/llibreguerra_2019_oi_190648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T17:57:41Z","timestamp":1613066261000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2757369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.17126","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]}}}